Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial membrane and protein iodination targets represent the collective molecular sites within pathogens—including bacteria, viruses, fungi, and protozoa—that are susceptible to the chemical actions of elemental iodine (StatPearls, 2023). The primary mechanism of action involves the rapid penetration of iodine through the microbial cell wall, followed by the iodination of amino acids such as tyrosine and histidine and the oxidation of essential sulfhydryl groups in proteins (Bigliardi et al., 2017). These reactions lead to the denaturation of enzymes and structural proteins, effectively neutralizing the microorganism's metabolic and reproductive capabilities (NCBI, 2021). Additionally, iodine reacts with unsaturated fatty acids in the cytoplasmic membrane, compromising its structural integrity and causing the leakage of vital cellular components (Journal of Hospital Infection, 2019). Because iodine targets multiple fundamental biochemical structures simultaneously, it possesses a broad spectrum of antimicrobial activity and a very low propensity for the development of resistance (PubMed, 2020). Clinically, these targets are exploited by iodophor-based antiseptics like povidone-iodine for surgical site preparation, wound care, and the prevention of infection (NIH, 2022). Understanding these targets is essential for evaluating the efficacy of iodine-releasing agents in various clinical and industrial applications.
Iodine acts as a strong oxidizing agent that rapidly penetrates microbial cell walls to iodinate amino acids (specifically tyrosine and histidine) and oxidize sulfhydryl groups (cysteine), leading to protein denaturation. It also reacts with unsaturated fatty acids in the microbial cell membrane, disrupting its physical structure and increasing permeability, which results in the leakage of cellular contents and rapid cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial membrane and protein iodination targets.